Antemortem-Postmortem Correlation of Florbetapir (18F) PET Amyloid Imaging with Quantitative Biochemical Measures of Aβ42 but not Aβ40
Antemortem-Postmortem Correlation of Florbetapir (18F) PET Amyloid Imaging with Quantitative Biochemical Measures of Aβ42 but not Aβ40
复制标题
DOI:
10.3233/jad-170762
复制
发表时间:
2018-01-01
影响因子:
4
通讯作者:
Roher, Alex E.
中科院分区:
文献类型:
--
作者:
Beach, Thomas G.;Maarouf, Chera L.;Roher, Alex E.
Amyloid imaging demonstrates the in vivo presence of amyloid-beta (A beta) deposits in the aging human brain but it is still unknown which structural forms and modifications of A beta are detected. In Alzheimer's disease, most amyloid deposits are predominantly composed of A beta ending at amino acid residues Val40 or Ala42. It has been reported that A beta(40) is largely restricted to neuritic plaques while A beta(42) may be deposited in amyloid plaques of all types, and is often the sole component of diffuse plaques. The distinction is important as it is mainly the neuritic plaques that correlate with cognitive impairment while diffuse plaques may be the initial type of A beta deposited. Whether PET amyloid ligands such as florbetapir18F (Amyvid) are partially or wholly selective for brain deposits of A beta(40) or A beta(42) is currently unknown. We compared antemortem florbetapir PET cortical/cerebellar signal intensity (SUVr) of 55 subjects with postmortem biochemical (ELISA) measurements employing specific antibodies against A beta(40) and A beta(42). Spearman's univariable correlations were significant for both A beta(40) and A beta(42), but were much stronger for A beta(42). Multiple linear regression showed significance only for A beta(42). These results suggest that florbetapir binds only weakly, if at all, to A beta(40). This may be in part due to the higher likelihood for A beta(42) to be present in a beta-pleated sheet tertiary structure, or to differences between A beta(40) and A beta(42) in beta-pleated sheet tertiary or quaternary structure.